ACET
Adicet Bio, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Adicet Bio, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Adicet Bio has 4 disclosed suppliers and 1 disclosed customer in SEC filings.
Adicet Bio, Inc.
3.41
SentenceAll of our revenue to date has been generated from the Regeneron Agreement, which is a collaboration and license agreement.
SentenceAdditionally, our non-exclusive license with the City of Hope provides access to their proprietary cytokine expression technology for cellular immunotherapy, which may also be material to the research, development and potential commercialization of ADI-212.
ACET 10-Kaccession 0001720580-26-000008
Expected move
No implied move.